ET on October 11 had reported that Zydus Cadila is the frontrunner for the Kraft Heinz India portfolio. Zydus Cadila is the country’s fourth-largest Indian pharmaceutical company with Rs 11,600 crore in FY18 sales.
ET on October 11 had reported that Zydus Cadila is the frontrunner for the Kraft Heinz India portfolio. Zydus Cadila is the country’s fourth-largest Indian pharmaceutical company with Rs 11,600 crore in FY18 sales.
